Skip to main content
logo
Prelude Therapeutics Incorporated (PRLD)
NASDAQ: PRLD · Real-Time Price · USD
3.775
+0.105 (2.86%)
At close: Oct 5, 2026, 4:00 PM EDT
3.770
-0.005 (-0.13%)
After-hours: Oct 5, 2026, 4:10 PM EDT

Prelude Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
38923997323287577
Market Cap Growth
238.21%147.03%-70.04%12.32%-50.21%-80.97%
Enterprise Value
255202-399365259
Last Close Price
3.772.901.274.276.0412.45

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
17.3219.6813.82---
PB Ratio
2.903.480.741.361.472.02
P/TBV Ratio
2.903.480.741.361.472.02

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
11.3416.63----

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.130.260.140.070.010.01
Net Debt / Equity Ratio
-1.00-1.25-0.88-0.91-1.02-1.01
Net Debt / EBITDA Ratio
2.080.840.841.651.642.57
Net Debt / FCF Ratio
4.031.521.121.952.303.37
Asset Turnover
0.150.080.03---
Quick Ratio
3.991.955.2110.679.3015.17
Current Ratio
4.071.995.3010.799.4215.37
Return on Equity (ROE)
-57.73%-99.45%-69.01%-56.34%-47.97%-44.85%
Return on Assets (ROA)
-27.15%-40.74%-38.54%-33.19%-29.38%-26.89%
Return on Capital Employed (ROCE)
-43.70%-116.90%-93.20%-51.70%-62.10%-39.80%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-15.58%-41.64%-131.47%-37.74%-40.16%-19.35%
FCF Yield
-8.56%-23.59%-107.16%-34.25%-30.18%-14.87%
Buyback Yield / Dilution
-10.91%-1.52%-25.60%-27.41%-2.87%-269.03%
SEC Filings: 10-K · 10-Q